Climedo, a Munich, Germany-based HealthTech company, raised €5m in seed financing.
The round was led by Nauta Capital with participation from Westtech Ventures and existing business angels such as Prof. Dr. Christian Wallwiener (WMC Healthcare).
The company will use the new capital for expanding within Europe and for further developing its software solutions. The objective is for the software to become patient-centric and to enable end-to-end communication between study coordinators, physicians and patients. There will also be more interfaces, e.g. to telemedicine and wearables.
Founded in 2017 by Sascha Ritz, Dragan Mileski and Veronika Schweighart, Climedo is a digital platform for electronic data capture in decentralized clinical trials. By capturing and processing real-time data in compliance with data protection regulations, the company not only enables approvals of drugs and medical devices, but can also be applied for post-market surveillance, where the safety and performance of products on the market are documented throughout their lifecycle.
Climedo’s EDC (Electronic Data Capture) system also includes an ePRO (electronic patient-reported outcomes) feature. Clinical trial subjects thereby keep an electronic patient diary which asks them about their daily symptoms, for example. It can be used on any device that has internet access – without the need for installing an app.
Climedo has already worked with hospitals such as Berlin’s Charité and numerous medical device manufacturers, pharma companies and contract research organizations.
The company currently employs around 50 people.
FinSMEs
16/02/2022